, APAC
/Freepik

Aon’s net income dips 1% YoY in H1 2024

This was equivalent to $1.63b.

Aon’s net income in the six months to June (H1 2024) dipped by 1% to $1.63b, attributable to a surge of 21% in expenses, but was partially offset by higher interest income and revenue.

In the second quarter, total revenue increased by 18% to $3.8b compared to the previous year, driven by acquired revenues from NFP and 6% organic revenue growth. This was slightly offset by a 1% negative impact from foreign currency translation. 

Likewise, the quarter’s net income contracted 6% to $538m.

Total operating expenses rose by 33% to $3.1b in Q1 2024, primarily due to NFP's ongoing operating expenses, charges from the Accelerating Aon United restructuring programme, increased expenses related to the 6% organic revenue growth, and investments in long-term growth. 

These increases were partially mitigated by $25m in restructuring savings and a $9m favourable impact from foreign currency translation.

However, adjusted net income per share increased by 6% to $2.93, including a $0.06 per share negative impact from foreign currency translation, compared to $2.76 in the prior year.

The company’s earnings per share (EPS) decreased 9% to $2.46, and adjusted EPS increased 6% to $2.93 

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.